Session Information
2007 Midyear Clinical Meeting
Blood Glucose Control in Type 2 Diabetes: Targeting the Incretin System
Track: Educational Session
Program Code: 275-L01
Date: Wednesday, December 5, 2007
Time: 8:00 a.m. - 9:50 a.m.
Location:
Venetian Ballroom CMEETING PLANNING ASSOCIATE:
Dr. Ujjaini Khanderia, MS, PharmD, Clinical Associate Professor and Clinical Pharmacist, University of Michigan Health System
MODERATOR:
Mr. Sharad Khanderia, MS, RPh, Clinical Instructor and Staff Pharmacist, University of Michigan Health System
PRESENTERS:
Dr. Ujjaini Khanderia, MS, PharmD, Clinical Associate Professor and Clinical Pharmacist, University of Michigan Health System
Dr. R. Keith Campbell, PharmD, MBA, Distinguished Professor of Pharmacy and Certified Diabetes Educator, Washington State University
Mr. Sharad Khanderia, MS, RPh, Clinical Instructor and Staff Pharmacist, University of Michigan Health System
LEARNING OBJECTIVES
- Discuss multihormonal regulation of blood glucose control in the pathophysiology of type 2 diabetes.
- Define the terms "incretin hormone" and "incretin effect" as they relate to type 2 diabetes.
- Explain the consequences of decreased incretin hormone effects in individuals with type 2 diabetes.
- Discuss the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of DPP-IV inhibitors and incretin mimetic drugs.
- State the potential place in therapy of incretin agents in the treatment of type 2 diabetes.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 275-L01)
This session is a part of: